IMMUNGLOBULINE UND GLYKOPROTEIDE BEI DER LYMPHOGRANULOMATOSE

Translated title of the contribution: Immunoglobulins and glycoproteins in lymphogranulomatosis

J. Fehér, L. Jakah, T. Pozsonyi, F. Graf

Research output: Contribution to journalArticle

Abstract

In the serum of 27 patients with malignant lymphogranulomatosis, the authors determined the serum level of glycoprotein-carbohydrate components (hexose, hexosamine, sialin acid, and seromucoid) and the concentration of 11 different glycoproteids. In the early stage of the disease, the immunoglobulin level is moderately increased in the serum, whereas a diminution can be observed in stage IV. The concentrations of ceruloplasmin, α-2-macroglobulin and orosomucoid were already increased significantly in stage III. The increase did not continue in state IV. In the final stage of the disease, the concentrations of α-1-antitrypsin and haemopexin turned out to be increased considerably. A significant decrease in the transferrin level could be registered in stage III with this diminution also continuing in the further course. Change of β-C-globulin and haptoglobin concentrations could not be evaluated statistically. The content of carbohydrate components in the glycoproteids will already increase in the early stage of the disease with this increase continuing in the further course. Among histological types there was a more significant increase of immunoglobulins in those forms rich of lymphocytes.

Translated title of the contributionImmunoglobulins and glycoproteins in lymphogranulomatosis
Original languageGerman
Pages (from-to)326-337
Number of pages12
JournalFolia Haematologica
Volume105
Issue number3
Publication statusPublished - 1978

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Immunoglobulins and glycoproteins in lymphogranulomatosis'. Together they form a unique fingerprint.

  • Cite this

    Fehér, J., Jakah, L., Pozsonyi, T., & Graf, F. (1978). IMMUNGLOBULINE UND GLYKOPROTEIDE BEI DER LYMPHOGRANULOMATOSE. Folia Haematologica, 105(3), 326-337.